The board of directors of the Association of Racing Commissioners International (RCI) voted without objection this week in favor of a resolution calling for the re-examination of whether its current policy pertaining to furosemide (Salix, commonly used to treat exercise-induced pulmonary hemorrhage in race horses) should be continued.
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.










